Lacunar Intervention Trial 1 (LACI-1)

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

November 30, 2017

Conditions
Cerebral Small Vessel DiseasesCognitive ImpairmentStroke
Interventions
DRUG

isosorbide mononitrate

slow release nitric oxide donor that enhances vasodilation and widely used in angina prophyaxis

DRUG

cilostazol

phosphodiesterase 3-inhibitor that enhances vessel wall function with weak antiplatelet effects

Trial Locations (2)

EH4 2XU

University of Edinburgh, Edinburgh

NG7 2RD

University of Nottingham, Nottingham

All Listed Sponsors
collaborator

University of Nottingham

OTHER

lead

University of Edinburgh

OTHER

NCT02481323 - Lacunar Intervention Trial 1 (LACI-1) | Biotech Hunter | Biotech Hunter